WeVote

Bill

Bill

SF 1069

Membership of the Rare Disease Advisory Council modification

2025-2026 Regular Session Introduced by Jim Carlson

Minnesota SF 1069 changes who can serve on the Rare Disease Advisory Council, altering membership rules, representation, and appointment processes.

Referred to Health and Human Services
0
WeVote Research Nonpartisan
Bill Summary · SF 1069

Summary of SF 1069 — Membership of the Rare Disease Advisory Council Modification

Overview

SF 1069 is a Minnesota bill titled “Membership of the Rare Disease Advisory Council modification.” The bill appears to focus on altering the membership composition of the state’s Rare Disease Advisory Council. The introduction is on February 6, 2025, and the bill has been referred to the Health and Human Services committee.

Purpose and intent

  • The title indicates the bill would modify who may serve on the Rare Disease Advisory Council and/or how council membership is determined.
  • Specific policy changes (e.g., number of members, eligibility, appointment process, terms, or categories of representation) are not provided in the summary text available here. Full bill text would be required to identify the exact changes and their rationale.

Key provisions (as far as publicly available information indicates)

  • The available summary confirms only that the bill concerns “Membership of the Rare Disease Advisory Council modification.”
  • Because the exact operative provisions are not included in the information provided, the precise changes to membership (e.g., which groups are added or removed, appointment procedures, term lengths, or voting rights) are not specified in this summary.
  • If enacted, the bill would be implemented according to the statute or administrative provisions governing the RDAC and any related broader health-council framework in Minnesota.

Who/what would be affected

  • Primary: Members of Minnesota’s Rare Disease Advisory Council and those involved in its appointment processes.
  • Secondary: Stakeholders who interact with or rely on RDAC activities, including patient advocacy groups, clinicians specializing in rare diseases, researchers, public health officials, and possibly organizations representing affected individuals and families.
  • The changes could affect council diversity of representation, expertise requirements, appointment timelines, and stakeholder engagement practices, depending on the final form of the provisions.

Procedural and timeline aspects

  • Introduced: February 6, 2025.
  • First reading: February 6, 2025.
  • Status: Referred to Health and Human Services. This indicates the bill will undergo committee consideration, where amendments and additional details typically are introduced and debated.
  • Next steps (if advanced): The Health and Human Services committee would review, possibly amend, and may hold hearings before sending the bill to the full chamber for a floor vote. If passed by one chamber, it would move to the other chamber and follow a similar process.

Notes and how to obtain more details

  • The summary provided does not include the bill’s full text or specific provisions. To understand the exact changes to RDAC membership, consult the official Minnesota Legislature bill text for SF 1069 and any fiscal notes or committee analyses.
  • For ongoing tracking, monitor the Health and Human Services committee hearings and subsequent floor actions in the legislature.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.